Eduardo Hallak, Juliana Neves, and Juliana Libman of Licks Attorneys examine how Brazil's new skinny-label regime may affect patent infringement claims, particularly those involving contributory infringement, when patented medical uses continue despite regulatory carve-outs
Senior legal practitioners of Licks Attorneys explain how antibody characterisation during prosecution can shape patent scope, validity, and enforcement in Brazil, with lessons from the US Amgen v Sanofi decision
